PriceTracker GLP-1

Mounjaro vs Rybelsus: a weekly shot against a pill Novo is replacing

Mounjaro is tirzepatide, a once-weekly injection; Rybelsus is semaglutide, a once-daily tablet. Both are type 2 diabetes drugs, and they have never been tested against each other. The bigger news for anyone choosing: Novo Nordisk says Rybelsus is being replaced by the Ozempic pill, which needs a new prescription. Paying cash, Mounjaro starts at $499 a month at LillyDirect, and Novo sells the Ozempic pill, not Rybelsus, at $149 to $299 a month.

7 min read · published October 2026

Studio still life: two unbranded pen injectors crossed at a shallow angle

Key takeaways

  • 1Different molecules and different routes: Mounjaro is a weekly tirzepatide injection, Rybelsus a daily semaglutide tablet.
  • 2Both are approved for type 2 diabetes, not weight loss, and both carry a heart-risk indication for high-risk adults.
  • 3Novo Nordisk says Rybelsus is being replaced by the Ozempic pill; moving over takes a new prescription.
  • 4No trial has put the two head to head. Their separate placebo trials are not a fair race.
  • 5Cash: Mounjaro from $499 a month at LillyDirect; Novo's self-pay pill is the Ozempic pill at $149 to $299 a month.

Mounjaro is a once-a-week injection of tirzepatide. Rybelsus is a once-a-day tablet of semaglutide. Both treat type 2 diabetes. They are different molecules from different companies, and no trial has ever compared them directly.

Before the comparison, one fact changes the question. Novo Nordisk's own support page for Rybelsus now opens with this line:1

RYBELSUS® is being replaced by Ozempic® pill.

NovoCare, Rybelsus page

So if you are weighing Mounjaro against Rybelsus in 2026, you are really weighing Mounjaro against oral semaglutide, sold more and more under the Ozempic name.

Mounjaro and Rybelsus side by side

MounjaroRybelsus
MoleculeTirzepatideSemaglutide
MakerEli LillyNovo Nordisk
How you take itInjection once a week2Tablet once a day, empty stomach3
Strengths2.5, 5, 7.5, 10, 12.5 and 15 mg pens23, 7 and 14 mg tablets1
Approved forBlood sugar in type 2 diabetes, age 10 and up; heart-risk reduction in high-risk adults2Blood sugar in adults with type 2 diabetes; heart-risk reduction in high-risk adults3
StatusSold by Lilly, including self-pay2Being replaced by the Ozempic pill1
Maker cash priceFrom $499 a month, LillyDirect2None for Rybelsus; the Ozempic pill from $149 a month, NovoCare4
In plain English

Neither one is approved for weight loss. Lilly's weight brand of tirzepatide is Zepbound, and Novo's weight pill is the Wegovy pill. Using a diabetes brand for weight is off-label: legal, common, and your prescriber's call.

What "being replaced" means for you

NovoCare answers the practical questions on the same page, and the answers are short:1

  • Is the new pill different medicine? Novo says the Ozempic pill at 1.5, 4 and 9 mg works like Rybelsus at 3, 7 and 14 mg, with "the same efficacy and safety". The numbers on the bottle change; the drug does not.
  • Do you need a new prescription? Yes. Your prescriber has to write the Ozempic pill and pick its strength.
  • Does your coverage carry over? Novo says the Ozempic pill "will have the same coverage as RYBELSUS®", with your cost set by your plan.
  • Does your savings offer carry over? Yes, you keep using it. No new sign-up.

That matters for this comparison because a choice of Rybelsus today is, in practice, a choice of the Ozempic pill within a refill or two. Everything below about Rybelsus applies to it.

The trials, and why they are not a race

There is no head-to-head trial of tirzepatide against oral semaglutide. What exists is one placebo-controlled trial of each, in adults with type 2 diabetes managed by diet and exercise alone.

SURPASS-1 (Mounjaro's molecule)PIONEER 1 (Rybelsus)
Length40 weeks626 weeks7
Doses5, 10, 15 mg weekly63, 7, 14 mg daily7
A1C change beyond placebo-1.91, -1.93, -2.11 points6-0.6, -0.9, -1.1 points7
Weight7.0 to 9.5 kg lost from baseline60.1, 0.9, 2.3 kg beyond placebo7
Most common side effectsMild to moderate stomach effects6Mild to moderate stomach effects7

The A1C gap looks large. Still, read the table as two separate studies, not a scoreboard. The trials ran for different lengths, enrolled different people, and the weight rows are not even measured the same way: one counts from the starting weight, the other only the loss beyond placebo. A cross-trial comparison is a hint, never a verdict.

Worth knowing

In SURPASS-1, nausea ran 12 to 18% on tirzepatide against 6% on placebo, diarrhoea 12 to 14% against 8%.6 PIONEER 1 also found stomach effects the most common, mostly mild and passing.7 Which drug you personally tolerate is not in either table.

The daily pill comes with rules

Rybelsus comes with instructions most pills do not. The maker's own words:3

Take 1 RYBELSUS® tablet by mouth on an empty stomach in the morning with water (no more than 4 ounces). Do not take RYBELSUS® with any other liquids besides water

RYBELSUS.com

Then 30 minutes before food, drink or other pills.3 Mounjaro is one injection a week from a single-dose pen.2 Some people would take a daily routine over a needle every time; others would take one shot over seven fasting mornings. Neither preference is wrong, and it is a fair thing to tell your prescriber.

What each costs without insurance

The makers' own published prices, read on 7 October 2026:

Per monthWhere
Mounjaro, any strengthFrom $499LillyDirect2
RybelsusNo published cash priceNovo points self-pay buyers to the Ozempic pill1
Ozempic pill, 1.5 to 9 mgFrom $149, varies by doseNovoCare Pharmacy4

The NovoCare page lists the Ozempic pill at $149, $199 and $299 a month across its three strengths, one bottle of 30 tablets a month.4 At the starting strength, a year of the Ozempic pill from NovoCare costs $1,788, against $5,988 for twelve months of Mounjaro at LillyDirect's $499.

With commercial insurance

Both makers run a card. Lilly's Mounjaro card brings a covered fill to as little as $25, with savings capped at $150 a month. If your plan does not cover Mounjaro, the same card can bring a month to as low as $499.5 Novo's offer for the Ozempic pill is as little as $25 with the saving capped at $100 a month, and it excludes government beneficiaries.4 A Rybelsus savings offer you already hold keeps working on the Ozempic pill.1

What our partner programs charge

Neither brand is sold by the telehealth programs we track. What they sell is the same two molecules, compounded, at prices we read off each seller's page:

Compounded drugs are not FDA-approved products, and they are a different purchase from Mounjaro or the Ozempic pill. The compounded semaglutide guide sets out what that means before you buy.

The honest summary

On the drug question, tirzepatide has the stronger trial numbers, but nobody has run the trial that would settle Mounjaro against Rybelsus, and the cross-trial gap is a hint, not proof. On the practical question, the pill side of this comparison is now the Ozempic pill, which NovoCare lists from $149 a month against LillyDirect's $499 for Mounjaro, and which needs a new prescription if you are on Rybelsus. On the route, it is a weekly shot against a daily fasting tablet. Take all three to your prescriber; the one you can stay on is the one that works.

Sources7
  1. NovoCare, Rybelsus product page (Novo Nordisk) read October 2026“RYBELSUS® is being replaced by Ozempic® pill. ... Ozempic® tablets 1.5 mg, 4 mg, 9 mg work similarly to RYBELSUS® tablets 3 mg, 7 mg, 14 mg and have the same efficacy and safety as RYBELSUS®. ... Yes, if you are currently taking RYBELSUS® you will need a new prescription to move to Ozempic® pill. ... Ozempic® pill will have the same coverage as RYBELSUS®. If you’re using insurance, your cost for Ozempic® pill will depend on your insurance plan. ... Patients can continue to use their offer to get a discount on Ozempic®. You don’t have to sign up for a new one.” ↩
  2. LillyDirect, Mounjaro self-pay price, uses and pen strengths (Eli Lilly) read October 2026“Once-weekly Mounjaro, along with diet and exercise, helps improve blood sugar in people with type 2 diabetes (T2D) aged 10+ and reduces the risk of major cardiovascular (CV) events (heart attack, stroke, or CV death) in adults with T2D at high risk for these events. ... Starting at $499/month ... Mounjaro is a prescription medicine available as a pre-filled single-dose pen in 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, or 15 mg per 0.5 mL injection.” ↩
  3. RYBELSUS.com, uses and how to take it (Novo Nordisk) read October 2026“Once-daily RYBELSUS® (semaglutide) tablets is a prescription medicine used along with diet and exercise to improve blood sugar in adults with type 2 diabetes, and to reduce the risk of major cardiovascular events in adults with type 2 diabetes who are at high risk for these events. ... Take 1 RYBELSUS® tablet by mouth on an empty stomach in the morning with water (no more than 4 ounces). Do not take RYBELSUS® with any other liquids besides water ... After 30 minutes, you can eat, drink, or take other oral medicines” ↩
  4. NovoCare Pharmacy, Ozempic pill and pen self-pay prices read October 2026“Self-pay pricing varies by dose. Eligibility and restrictions apply. One month is defined as 1 bottle of 30 tablets. ... There are self-pay options starting at $149/month if your commercial insurance doesn’t cover your medication, or if you are uninsured. ... Pay as little as $25, subject to a maximum savings of $100/month. Eligibility and restrictions apply. Government beneficiaries excluded.” ↩
  5. Eli Lilly, Mounjaro savings card terms read October 2026“You must have commercial drug insurance that covers Mounjaro® (tirzepatide) and a prescription for an approved use consistent with FDA-approved product labeling to pay as little as $25 for a 1-month, 2-month, or 3-month prescription fill of Mounjaro single-dose pen. ... Card savings are subject to a maximum monthly savings of up to $150 per 1-month prescription ... and a separate maximum annual savings of up to $1,950 per calendar year. ... You must have commercial drug insurance that does not cover Mounjaro and a prescription for an approved use consistent with FDA-approved product labeling to pay as low as $499 for a 1-month prescription fill of Mounjaro single-dose pen.” ↩
  6. SURPASS-1, Rosenstock et al., Lancet 2021;398:143-155 (PubMed abstract) read October 2026“We did a 40-week, double-blind, randomised, placebo-controlled, phase 3 trial (SURPASS-1) ... Participants were randomly assigned (1:1:1:1) via computer-generated random sequence to once a week tirzepatide (5, 10, or 15 mg), or placebo. ... resulting in estimated treatment differences versus placebo of -1·91% (-21 mmol/mol) with tirzepatide 5 mg, -1·93% (-21 mmol/mol) with tirzepatide 10 mg, and -2·11% (-23 mmol/mol) with tirzepatide 15 mg (all p<0·0001). ... Tirzepatide induced a dose-dependent bodyweight loss ranging from 7·0 to 9·5 kg. The most frequent adverse events with tirzepatide were mild to moderate and transient gastrointestinal events, including nausea (12-18% vs 6%), diarrhoea (12-14% vs 8%), and vomiting (2-6% vs 2%).” ↩
  7. PIONEER 1, Aroda et al., Diabetes Care 2019;42:1724-1732 (PubMed abstract) read October 2026“This was a 26-week, phase 3a, randomized, double-blind, placebo-controlled, parallel-group trial ... randomized (1:1:1:1) to once-daily oral semaglutide 3 mg, 7 mg, 14 mg, or placebo. ... oral semaglutide reduced HbA1c (placebo-adjusted treatment differences at week 26: treatment policy estimand, -0.6% [3 mg], -0.9% [7 mg], and -1.1% [14 mg]; ... and body weight (treatment policy, -0.1 kg [3 mg], -0.9 kg [7 mg], and -2.3 kg [14 mg, P < 0.001]; ... Mild-to-moderate transient gastrointestinal events were the most common adverse events with oral semaglutide.” ↩

Common questions

Is Mounjaro better than Rybelsus?

No trial has compared them directly. In separate placebo-controlled trials, tirzepatide (Mounjaro) lowered A1C by 1.91 to 2.11 points beyond placebo over 40 weeks, and oral semaglutide (Rybelsus) by 0.6 to 1.1 points over 26 weeks. The trials differ in length and design, so that gap is a hint, not a head-to-head result. Which is better for you is a prescriber's decision.

Is Rybelsus being discontinued?

Novo Nordisk's NovoCare page says Rybelsus is being replaced by the Ozempic pill. Novo says the Ozempic pill at 1.5, 4 and 9 mg works like Rybelsus at 3, 7 and 14 mg with the same efficacy and safety. Moving over needs a new prescription; coverage and an existing savings offer carry over.

What is the difference between Mounjaro and Rybelsus?

Mounjaro is tirzepatide from Eli Lilly, injected once a week. Rybelsus is semaglutide from Novo Nordisk, taken as a tablet once a day on an empty stomach with no more than 4 ounces of water, 30 minutes before food, drink or other pills. Both are approved for type 2 diabetes and for heart-risk reduction in high-risk adults with type 2 diabetes.

Can you take Mounjaro or Rybelsus for weight loss?

Both are approved for type 2 diabetes, not weight loss, so using either for weight is off-label and a prescriber's decision. The weight-loss brand of tirzepatide is Zepbound, and the semaglutide pill approved for weight is the Wegovy pill.

How much do Mounjaro and Rybelsus cost without insurance?

LillyDirect sells Mounjaro from $499 a month. Novo publishes no cash price for Rybelsus; its NovoCare Pharmacy sells the Ozempic pill instead, at $149, $199 and $299 a month across its three strengths.

Is there a savings card for Mounjaro or Rybelsus?

Yes, for people with commercial insurance. Lilly's Mounjaro card brings a covered fill to as little as $25, capped at $150 a month. Novo's offer brings the Ozempic pill to as little as $25, capped at $100 a month, and a Rybelsus offer you already hold keeps working on the Ozempic pill. Government beneficiaries are excluded from Novo's offer.

Choosing a program? See our ranking of the best online GLP-1 programs for every partner side by side, or the cheapest tirzepatide page for price alone.

Read next